Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Updated on: August 14,2024 0

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Updated on:August 14,2024 0

Study Warns: Common Antibiotics Can Trigger Severe Skin Reactions

Updated on: August 13,2024 0

Study Warns: Common Antibiotics Can Trigger Severe Skin Reactions

Updated on:August 13,2024 0

US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

In a significant leap forward for dental care, Boston-based company Perceptive has announced the completion of the world's first fully automated dental procedure on a human.

Updated on: August 13,2024 0

US AI Company Achieves World's First Fully Automated Dental Procedure on a Human

In a significant leap forward for dental care, Boston-based company Perceptive has announced the completion of the world's first fully automated dental procedure on a human.

Updated on:August 13,2024 0

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.

Updated on: August 13,2024 0

Celebrating Innovation in Life Sciences: The 2024 Prix Galien USA Awards

The Prix Galien is often regarded as the equivalent of the Nobel Prize in biopharmaceutical research, highlighting its significance in the scientific community.

Updated on:August 13,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024 0

A non-canonical mechanism for RNA damage compartmentalization and daughter cell protection

Updated on: August 08,2024 0

A non-canonical mechanism for RNA damage compartmentalization and daughter cell protection

Updated on:August 08,2024 0

Scientists discover mast cells trap and use living neutrophils during allergic reactions

byMax Planck Institute of Immunobiology and EpigeneticsThis scanning electron microscopy image captures the moment where degranulating mast cells (pseudo-colored in sepia) attract and start to i

Updated on: August 08,2024 0

Scientists discover mast cells trap and use living neutrophils during allergic reactions

byMax Planck Institute of Immunobiology and EpigeneticsThis scanning electron microscopy image captures the moment where degranulating mast cells (pseudo-colored in sepia) attract and start to i

Updated on:August 08,2024 0

Research team investigates difference between baby formula and human milk's effect on intestinal growth

by Alexa Tomassi,Yale School of MedicineCredit: Unsplash/CC0 Public DomainAn articlepublished inGastro Hep Advancesby a team of Yale researchers and led by Lauren Smith, MD, ho

Updated on: August 08,2024 0

Research team investigates difference between baby formula and human milk's effect on intestinal growth

by Alexa Tomassi,Yale School of MedicineCredit: Unsplash/CC0 Public DomainAn articlepublished inGastro Hep Advancesby a team of Yale researchers and led by Lauren Smith, MD, ho

Updated on:August 08,2024 0

Positive parenting strategies can reduce child maltreatment

byUniversity of QueenslandOrganization engagement by local government area. Credit:Child Maltreatment(2024). DOI: 10.1177/10775595241259994University of Queensland research shows chi

Updated on: August 08,2024 0

Positive parenting strategies can reduce child maltreatment

byUniversity of QueenslandOrganization engagement by local government area. Credit:Child Maltreatment(2024). DOI: 10.1177/10775595241259994University of Queensland research shows chi

Updated on:August 08,2024 0

Wound healing checked in real time with electronic suture

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Schematic illustrations of (a) the Au-based fiber electrode serves as a base electrode for the working and reference electrodes, (c) the P

Updated on: August 08,2024 0

Wound healing checked in real time with electronic suture

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Schematic illustrations of (a) the Au-based fiber electrode serves as a base electrode for the working and reference electrodes, (c) the P

Updated on:August 08,2024 0

New research into life-threatening birth defect of the diaphragm

by Birgit Pfeiffer,Leipzig UniversityHypoplastic lungs of human fetuses with CDH have increased macrophage density and up-regulation of inflammatory mediators. Credit:Science Advances&nbsp

Updated on: August 08,2024 0

New research into life-threatening birth defect of the diaphragm

by Birgit Pfeiffer,Leipzig UniversityHypoplastic lungs of human fetuses with CDH have increased macrophage density and up-regulation of inflammatory mediators. Credit:Science Advances&nbsp

Updated on:August 08,2024 0

Doctors, apps and artificial intelligence - The future of medicine

Updated on: August 07,2024 0

Doctors, apps and artificial intelligence - The future of medicine

Updated on:August 07,2024 0